NCT07548840
- Conditions
- Hyperphosphatemia Patients on Hemodialysis
- Locations
-
- Taisho selected site Tokyo, Japan
Clinical trial condition
Hyperphosphatemia Patients on Hemodialysis
Explore clinical trials studying Hyperphosphatemia Patients on Hemodialysis. Study availability and eligibility vary by location and protocol.
6 public trials
3 recruiting studies
Hyperphosphatemia Patients on Hemodialysis trial results
Recruiting
A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders
NCT07285291
- Conditions
- Hyperphosphatemia Patients on Hemodialysis
- Locations
-
- Taisho Pharmaceutical Co., Ltd selected site Tokyo, Japan
NCT07285304
- Conditions
- Hyperphosphatemia Patients on Hemodialysis
- Locations
-
- Taisho Pharmaceutical Co., Ltd selected site Tokyo, Japan
NCT06745531
- Conditions
- Hyperphosphatemia Patients on Hemodialysis
- Locations
-
- Taisho Pharmaceutical Co., Ltd selected site Tokyo, Japan
Completed
A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders
NCT06745518
- Conditions
- Hyperphosphatemia Patients on Hemodialysis
- Locations
-
- Taisho Pharmaceutical Co., Ltd selected site Tokyo, Japan
NCT05699239
- Conditions
- Hyperphosphatemia Patients on Hemodialysis
- Locations
-
- Taisho Pharmaceutical Co., Ltd selected site Tokyo, Japan